These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18674946)

  • 1. Efficacy of anakinra in a patient with refractory relapsing polychondritis.
    Wendling D; Govindaraju S; Prati C; Toussirot E; Bertolini E
    Joint Bone Spine; 2008 Oct; 75(5):622-4. PubMed ID: 18674946
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications of anakinra].
    Chauffier K; London J; Beaudouin C; Fautrel B
    Presse Med; 2009 May; 38(5):799-807. PubMed ID: 19278814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital Relapsing Polychondritis: A Unique Presentation, Complication, and Treatment.
    Moore GH; Rootman DB; Roybal CN; Goldberg RA
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):e34-6. PubMed ID: 25072220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained remission of pediatric relapsing polychondritis with adalimumab.
    Navarrete VM; Lebrón CV; de Miera FJ; Candau CP; Sarabia FN
    J Clin Rheumatol; 2014 Jan; 20(1):45-6. PubMed ID: 24356482
    [No Abstract]   [Full Text] [Related]  

  • 5. Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra).
    Vounotrypidis P; Sakellariou GT; Zisopoulos D; Berberidis C
    Rheumatology (Oxford); 2006 Apr; 45(4):491-2. PubMed ID: 16510529
    [No Abstract]   [Full Text] [Related]  

  • 6. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.
    Nigrovic PA; Mannion M; Prince FH; Zeft A; Rabinovich CE; van Rossum MA; Cortis E; Pardeo M; Miettunen PM; Janow G; Birmingham J; Eggebeen A; Janssen E; Shulman AI; Son MB; Hong S; Jones K; Ilowite NT; Cron RQ; Higgins GC
    Arthritis Rheum; 2011 Feb; 63(2):545-55. PubMed ID: 21280009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained response to infliximab in 2 patients with refractory relapsing polychondritis.
    Saadoun D; Deslandre CJ; Allanore Y; Pham XV; Kahan A
    J Rheumatol; 2003 Jun; 30(6):1394-5. PubMed ID: 12784426
    [No Abstract]   [Full Text] [Related]  

  • 8. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
    Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
    Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of relapsing polychondritis with infliximab.
    Richez C; Dumoulin C; Coutouly X; Schaeverbeke T
    Clin Exp Rheumatol; 2004; 22(5):629-31. PubMed ID: 15485019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid sparing effect of methotrexate in relapsing polychondritis.
    Park J; Gowin KM; Schumacher HR
    J Rheumatol; 1996 May; 23(5):937-8. PubMed ID: 8724312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome.
    Kahn PJ; Cron RQ
    J Rheumatol; 2013 May; 40(5):743-4. PubMed ID: 23637382
    [No Abstract]   [Full Text] [Related]  

  • 12. Abatacept for relapsing polychondritis.
    Moulis G; Sailler L; Astudillo L; Arlet P
    Rheumatology (Oxford); 2010 May; 49(5):1019. PubMed ID: 20071448
    [No Abstract]   [Full Text] [Related]  

  • 13. Relapsing polychondritis: new therapeutic strategies with biological agents.
    Buonuomo PS; Bracaglia C; Campana A; El Hachem M; Diociaiuti A; Insalaco A; De Benedetti F; Testa BC; Cortis E; De Vincentiis GC; Ugazio AG
    Rheumatol Int; 2010 Mar; 30(5):691-3. PubMed ID: 19685056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis.
    Cazabon S; Over K; Butcher J
    Eye (Lond); 2005 Feb; 19(2):222-4. PubMed ID: 15258602
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab.
    Mpofu S; Estrach C; Curtis J; Moots RJ
    Rheumatology (Oxford); 2003 Sep; 42(9):1117-8. PubMed ID: 12923271
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of Anakinra in Acute Gout: A Retrospective Review of Initial and Refractory Therapy.
    Petite SE
    Am J Ther; 2017; 24(5):e633-e634. PubMed ID: 27763889
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anakinra in a case of fever familial Mediterranean].
    Ferris Villanueva E; García Coronel M; Guerrero Bautista R
    Farm Hosp; 2014 Sep; 38(5):446-8. PubMed ID: 25344140
    [No Abstract]   [Full Text] [Related]  

  • 19. Relapsing polychondritis in childhood--case report and short review.
    Knipp S; Bier H; Horneff G; Specker C; Schuster A; Schroten H; Lenard HG; Niehues T
    Rheumatol Int; 2000; 19(6):231-4. PubMed ID: 11063294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory case of Schnitzler's syndrome.
    Kluger N; Rivière S; Guillot B; Bessis D
    Acta Derm Venereol; 2008; 88(3):287-8. PubMed ID: 18480937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.